Children’s Hospital GME Support Reauthorization Act of 2025

Extension of Program Funding: The bill extends the timeline for the program of payments to children's hospitals to include fiscal year 2030 (Section 2, subsection (a) and (b)(3)(D)). This provides continued financial support for hospitals operating graduate medical education programs.

Increased Annual Funding Allocations: The bill adds specific funding amounts for fiscal years 2026 through 2030, including $124,000,000 for one provision and $261,000,000 for another (Section 2, subsection (f)).

Protections for Specific Medical Needs: The bill includes exceptions that allow for treatments related to precocious puberty, medically verifiable genetic disorders of sex development, or situations where a procedure is necessary to prevent imminent danger of death or impairment of a major bodily function (Section 2, subsection (g)(4)(B)).

Loss of Hospital Payments: Hospitals may lose their payments if they furnish "specified procedures and drugs" to individuals under 18 years of age (Section 2, subsection (e)(4)(A)).

Restrictions on Specific Medical Procedures and Medications: Hospitals are prohibited from providing certain surgeries—such as mastectomies, scrotoplasty, or various other gender-related surgeries—and medications like puberty-blocking drugs or high levels of estrogen and testosterone to minors (Section 2, subsection (g)(4)(A)).

Financial Risk for Hospitals Providing Certain Care: Because the prohibition applies if a hospital furnishes these services "at any point during the preceding fiscal year," it creates a risk that providing specific care to a minor could disqualify the entire institution from receiving program payments (Section 2, subsection (e)(4)(A)).